What weight loss from Wegovy actually looks like

You've read the headline figure. Here's what it means in practice.

Picture this: you've seen the 15% average quoted on several websites and you're trying to work out what it would mean for you specifically. The honest answer is that 15% is a population mean, some people in the STEP 1 trial lost considerably more, others less. A third of participants lost more than 20% of their starting weight; a smaller group lost under 5%. Biology, starting weight, how consistently doses are taken, and lifestyle changes all pull the result in different directions.

What the trial does confirm is that the effect is real and meaningful at a population level. For context, treatments that produce more than 10% average weight reduction are considered clinically significant in obesity medicine, semaglutide cleared that bar substantially. The NHS summarises the mechanism and expected outcomes on its semaglutide medicines page, which is worth reading alongside any clinic information you receive.

If you want to understand how the active ingredient drives those results, our guide to semaglutide and weight loss explains how it works in the body and what the evidence shows. Appetite signals quiet down, feelings of fullness come sooner, and gastric emptying slows. You eat less not because you are forcing yourself, but because hunger genuinely reduces. That shift in appetite is why the medicine needs to be paired with dietary changes and activity rather than relied upon alone, the two reinforce each other.

One practical habit worth building early: weigh yourself on the same day each week, same time, same scales. A single weekly number is more informative than daily fluctuations, and it gives your prescriber useful data at every review. Takes under a minute, and the pattern it reveals over months is far more meaningful than any individual reading.

The titration schedule and when weight loss tends to accelerate

Wegovy does not start at its full strength. The prescribing schedule moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and then 2.4 mg, with roughly four weeks at each level. That graduated approach exists because the GI side effects (nausea, loose stools, burping) are dose-related, and slower escalation gives your system time to adjust.

The practical consequence is that the first two to three months are a settling-in period. Some people notice appetite changes and modest weight loss during this phase; others find the effect becomes much more pronounced once they reach the higher doses. Neither pattern is wrong. Comparing your week-six result to someone else's month-five result is not a fair comparison.

If you are curious about how the titration schedule compares between Wegovy and tirzepatide, the Wegovy overview page covers both medicines side by side. And if cost is a factor in your thinking, the Wegovy cost and what's included page sets out what a legitimate private prescription typically covers, so you can compare providers on equal terms. For a broader look at how semaglutide works as a medicine, the semaglutide information page goes into the mechanism in more depth.

The MHRA approved a 7.2 mg single-dose pen in April 2026, a higher maintenance option for adults with a BMI of 30 or above. If you want a full picture of what Wegovy weight loss involves, including what realistic outcomes look like at different doses, that page brings together the key evidence in one place. Whether a specific dose or pen format is available is always confirmed at the point of consultation, not before.

Side effects that may affect how your weight loss goes

The most common reason people lose less weight than the trial average is that side effects interrupt treatment. Nausea is the most frequently reported, particularly in the early weeks and after each dose increase. It usually settles within days, but for some people it is severe enough to affect eating patterns in ways that are not planned or healthy, eating very little because everything feels unappetising is not the same as a structured calorie deficit.

Other GI effects include constipation, diarrhoea, indigestion and fatigue. Most are mild to moderate and transient. Staying well hydrated, eating smaller meals, and avoiding very fatty or very large portions can reduce their intensity. Your prescriber and the Patient Information Leaflet will give you specific guidance for your situation.

There are also rarer but more serious signs that need urgent attention: severe stomach pain that radiates toward the back could indicate pancreatitis, a known though infrequent risk the MHRA highlighted in a Drug Safety Update in January 2026. Gallbladder symptoms, signs of dehydration from prolonged vomiting or diarrhoea, or any allergic reaction should prompt immediate medical contact. If you have questions about how side effects are managed, the FAQs page covers the most common ones, or you can reach the team directly through the contact page.

Wegovy is not recommended during pregnancy, breastfeeding, or when actively trying to conceive. It is not licensed for anyone under 18. Women using oral contraceptives should discuss whether any additional contraceptive precautions apply with their prescriber before starting.

Getting started: what the private route looks like

Wegovy is a prescription-only medicine, which means the only lawful way to obtain it is through a clinical assessment by a registered prescriber. On the NHS, access is via specialist weight management services under NICE guidance, waiting lists are long in most areas, and eligibility criteria are strict. The Wegovy from a GP page explains the NHS route in detail.

A regulated private pharmacy offers an alternative for people who do not meet NHS thresholds or who do not want to wait. At nume, a GPhC-registered Independent Prescriber reviews every consultation personally, not software, not a template. Before making any decision, it is worth understanding what Wegovy offers as a weight loss medicine, including how it compares to other options, and how the medicine fits into a wider weight management plan. Our clinical team page gives a fuller picture of how oversight works at every stage.

If you are ready to find out whether Wegovy is clinically appropriate for you, start your free consultation and a prescriber will review your details the same day.